Open Orphan plc (OPORF PINK) stock market data APIs
$0.2423
0(0%)
as of May 16, 2025
Try our APIs with
free plan!
Open Orphan plc Financial Data Overview
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in testing of vaccines and antivirals using human challenge clinical trials; and offers laboratory services, including assay development, cell based assays, molecular, immunology, virology, clinical field trail logistics, and biomarker analysis services. It has a portfolio of human challenge study models for conditions, such as RSV, influenza, COVID-19, hMPV, HRV, asthma, malaria, and COPD. In addition, the company offers specialized virology and immunology laboratory, which offers a suite of services to support pre-clinical and clinical respiratory drug; and vaccine discovery and development. Further, it provides preclinical and early clinical research services; sales and marketing services; data management; and statistics services, as well as drug development consultancy and services. The company offers services to big pharma and biotech organizations. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
Prev. Close
0.2423
Open
0.2423
High
0.2423
Low
0.2423
52 wk Range
0.2373-0.3644
Market Cap
165 M
P/E Ratio
12
Shares Outstanding
687 M
Revenue
66 217 K
EPS
0.0013
Dividends (Yield)
0.0107
Beta
1.345
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Open Orphan plc data using free add-ons & libraries
Get Open Orphan plc Fundamental Data
Open Orphan plc Fundamental data includes:
- Net Revenue: 66 217 K
- EBITDA: 13 951 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Open Orphan plc News
New
hVIVO CEO reports on "very strong" H1 2023
London, UK --News Direct-- hVIVO PLC hVIVO PLC (AIM:HVO) chief executive Mo Khan speaks to Thomas Warner from Proactive after the specialist contract research organisation released a trading update f...
hVIVO signs second bespoke human challenge model contract in as many months
London, UK --News Direct-- hVIVO PLC hVIVO PLC (AIM:HVO) chief executive Mo Khan speaks to Thomas Warner from Proactive after announcing that the specialist contract research organisation has begun w...
Loss-Making hVIVO plc (LON:HVO) Set To Breakeven
hVIVO plc (LON:HVO) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. hVIVO plc operates as a pharmaceutical service and contract resear...
hVIVO plc's (LON:HVO) Shares Not Telling The Full Story
You may think that with a price-to-sales (or "P/S") ratio of 2.1x hVIVO plc (LON:HVO) is a stock worth checking out, seeing as almost half of all the Life Sciences companies in the United Kingdom have...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
